Table 7 Performances of Approach B (Model 4) in defining the rate of patients unnecessarily explored or inappropriately unexplored

From: Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial

Model 4

PIV

Unnecessarily explored (1−NPV) (%)

Inappropriately unexplored (1−PPV) (%)

0

8.0

37.1

1

25.4

22.6

2

36.3

18.3

3

49.7

7.2

4

54.7

0

Back to article page